IMO Grup Miranza, a reference center for retinal problems

Diseases affecting the retina can seriously compromise vision and overall quality of life. Pathologies such as retinal detachment, age-related macular degeneration (AMD), or diabetic retinopathy can cause irreversible vision loss and, in some cases, lead to blindness. IMO Grup Miranza addresses problems affecting this part of the eye with a multidisciplinary and specialized approach.

The clinic's team of ophthalmologists is expert in medical treatments, surgical procedures, new drugs and diagnostic technology, as well as future gene therapies. They all work closely together to help visitors see better.

Advances in medical treatments

One of the main advances is the number of diseases that can be treated in the clinic with intraocular injections. "These are a type of therapy in which we inject a drug into the eye (antiangiogenic) using a very fine needle. They are capable of slowing and improving—almost always—the vision of people suffering from one of the most prevalent pathologies worldwide: AMD (age-related macular degeneration). This treatment, also indicated for visual complications derived from diabetes (such as diabetic retinopathy or diabetic macular edema) and other retinal lesions, continues to evolve. In fact, they have more effective drugs that last longer inside the eye, which significantly reduces the number of injections.

This contributes to improving the quality of life of those affected, as they require fewer treatments per year. Regarding the other type of AMD, dry AMD, "unfortunately, there is still no treatment, but we have very promising research projects underway." In fact, IMO Grup Miranza was the first center in Spain to test gene therapy to slow the progression of the disease, which already affects nearly one million people in Spain, and continues to lead genetic research for the development and application of future therapies.

Experts in surgical techniques

Using extremely fine and precise instruments, about the thickness of a needle, surgeons at the IMO Grup Miranza manipulate the structures within the eye and treat potentially serious conditions that, in certain cases, can lead to blindness. This is the case with retinal detachment, diabetic retinopathy, macular holes, and complications arising from high myopia.

In this regard, retinologists—ophthalmologists specializing in the retina—point out that some retinal diseases currently have a more favorable prognosis, thanks to better control and treatment. However, they have detected an increase in cases of retinal detachment, something they link to the rise in myopia (50% of patients who develop this condition are nearsighted) and the increase in life expectancy. This potentially serious condition requires immediate attention, since, if not treated promptly, it can cause irreversible vision loss.

In the operating room, machines have been developed that allow for the control of key aspects of retinal surgery, such as highly precise control of eyeball pressure and excellent illumination and visualization of intraocular structures. Furthermore, high-precision surgical instruments, necessary, for example, to extract the vitreous and manipulate the retina, have also been greatly improved.